Studies on MM xenograft murine models showed that low dose of splicing modulators, including sudemycin and meayamycin, also shifts apoptotic dependence in MM cells, thus enhancing their sensitivity to venetoclax, irrespectively of SFs mutations, MYC expression level, and t(11;14) [89]. Here, MYC is linked to Miyoshi myopathy.